厚生労働省医政局経済課 委託事業
後発医薬品使用促進ロードマップ検証検討事業
報告書
平成30年3月
..................................................................................................................................... 1
.................................................................................................................................. 3 .................................................................................................................................. 3
.............................................................................................................................. 4 .............................................................................................................................. 5
........................................................................................................................... 7 ....................................................................................................................... 7 ....................................................................................................................... 9
............................................................................................................ 9 ................................................................................ 34
....................................................................................... 76 ................................................................................ 86 .............................................................................. 105
....................................................................................................................... 115 23 ............................................................................................... 117
..................................................................................................... 117 ..................................................................................................... 118
.......................................................... 118 ...................................................... 133
.......................... 138 ........................................................................ 151
................................................................................................. 163 ................................................................................................. 164
........................................................................ 164 ............................................................................ 174
.............................................................. 178 ..................................................................................................... 182
................................................................................................................... 182 ................................................................................................................... 183
................................................................................................. 183 ........................................................................................................ 201
.......................................................................................... 211 ........................................................................ 250
.......................................................................................................................... 307 ................................................................................................................... 309 ................................................................................................................... 310
....................................................................................................................... 310 ....................................................................................................................... 322
................................................................................................................... 332 ........................................................................................................ 345
...................... 359 ....................................................................................................................... 361
........................................................................................................ 361 ...................................................... 365
.......................................................................................... 371 ........................................................................................................ 371
.............................................................................................. 373 ...................................................... 374
............................................................................................................ 377 .............................................................................................. 377
...................................................... 379 .............................................................................................. 381
........................................................................................................ 381 .............................................................................................. 386
...................................................... 389 ................................................................................................. 391 ................................................................................................. 392
........................................................................................................ 392
1
1
2
2
3
25 4
26 4
196
105
23 47 23
3,500 2,500
3
4
17
31
29 11 29
230 2 16UFJ
23
330 3 16UFJ
2 3 42 5 5 6
MR Medical Representative
MRMR
MS Marketing Specialist
MS MS
4
5
2 100
5
6
6
7
196 29 10 1
29 12 15 30 1 25
28 29
28
25 26 27
3 UFJ 26 27
28 3 27
28 29 3 UFJ
28 29 3 28
29 3 2
25 26 27
7
8
105 29 10 1
29 12 15 30 1 24
28 29
28
29 3 28 29 3
1
8
9
� 5,000 1 25.5
1 5 10
4 1
� 1 21.0 100 24.0
9
10
10
11
� 85.9
14.1
� 74.0 26.0
11
12
� 100 500 26.1
500 22.8
� 500 55.0
3 3
12
13
3 29 3
13
14
MR
� 1 671.1 MR
170.1 MR MR 165.4
� 1 MR 25 212.3 26
204.4 27 188.5 28 170.1
� 1 1,713.6 MR
466.0 MR MR 461.8
MR MR
14
15
MR MR
15
16
� 9
84 10 19 30
� 100 26 27 9
4 100 1
� 4
38 10 19 20 30
18
16
17
17
18
�
79.7 27 1.9
256
� MF
35.0 27 MF
45.0 27
3.8
� 40.0
27 1.9
5.0 27
� 33.5 27 1.0
125
� MF
38.6 MF
50.3
� 46.6
13.1
18
19
19
20
�
B A 50 8
�
53.2 27 3.8
%
20
21
� 90
� 27 90
90
21
22
�
93.5 172 6.5 12
� 95.0 95 5.0 5
22
23
� 22.3
41 77.7 143
� 9.0 9 91.0 91
27
23
24
� 0
21.7 0 20 29 21.7
� 20 29
27.0 40 49 24.0 0 20.0
24
25
25
26
� 0
26.6 27 5.6 0 1
16.8
� 0
46.0 1 22.0
26
27
� 156
145 92.9 54 34.6
�
1,186 185
� 167 147
88.0 146 87.4
� 2,623
3,864
� 96
93 96.9 34 35.4
�
528 136
� 96 73
76.0 80 83.3
� 491
622
27
28
7 3 2 22
3 2 22
15 14 13 6 65 4 4 4 3
3 3 3 3 33 2 2 2 2
28
29
8 5 4 43 2 2
4 3 22
16 15 8 75 4 4 2 2
29
30 30
31 31
32
�
1.26
5.70
�
1.48
5.86
32
33
33
34
1
�
49.5 92 26.9
50
� 54.5 55
22.8 23
25
25 26 27 3 28 29 11
34
35
1
27 28 3 28 29 11
35
36
27 28 3 28 29 11
36
37
2
� 92.6 125
27 3
� 90.9 70
2525 26 27 3 28 29 11
37
38
27 28 3 28 29 11
27 28 3 28 29 11
38
39
3
�
50.0 5
� 27
25
10
25 26 27 3 28 29 11
1
39
40
4
�
23 692
� 27
260
� 12
164
25 26 12 1 26 27 11 1 2728 11 1 28 29 11 1
40
41
5
�
76.3 103
� 63.6 49
2525 26 27 3 28
29 11
41
42
27 28 3 28 29 11
27 28 3 28 29 11
42
43
1
�
81.2 151 18.3
34
� 27 5
�
56.4 57 41.6 42
25
25 26 11 26 27 11 2728 11 28 29 11
43
44
27 28 11 28 29 11
27 28 11 28 29 11
44
45
2
�
28 11 82.8 125 28 12
8.6 13
3
�
� 1
�
�
�
�
�
�
�
45
46
�
�
� 1
�
�
� 30
�
4
�
20.6 7
73.5 25
30 3 2 30 6 2
30 7 1 30 8 1 30 12 1
46
47
5
�
83.9 156 14.0 26
� 27 5
25 26 12 26 27 11 2728 11 28 29 11
27 28 11 28 29 11
47
48
27 28 11 28 29 11
6
�
�
� 1
�
�
�
�
�
�
�
�
48
49
7
�
95.2 177 3.2 6
� 93.1 94 5.0 5
25 26 12 26 27 11 2728 11 28 29 11
49
50
27 28 11 28 29 11
27 28 11 28 29 11
50
51
8
�
�
�
�
�
�
�
�
�
�
� 1
51
52
1
�
79.3 146 19.0 35
� 74.0 74
22.0 22
2.0 2
2 3 4 2 5 56
2 3 4 2 5 56
52
53
53
54
2
� 5.5 10
93.9 170
� 5.2 5 94.8 91
54
55
� 28 21 5
55
56
3
�
95.2 76.2
71.4
52.4
�
60.0
40.0
20.0
56
57
28 5
57
58
4)薬価収載後 5 年以内の後発医薬品のうち供給停止した品目数
薬価収載後 5 年以内の後発医薬品のうち供給停止した品目数は 12 品目であり、このうち、供
給停止 3 か月前までにすべての納入先保険医療機関等に直接お知らせできたのは 12 品目(全
品目)、保険医療機関等に代替品等の情報を提供したのは 12 品目(全品目)であった。
薬価収載後 5 年以内の後発医薬品のうち供給停止した品目名とその理由は以下のとおりであ
った。
図表 1- 75 薬価収載後 5年以内の後発医薬品のうち供給停止した品目数
(各年度中、複数規格がある製品の一部規格で発生した供給停止等を含む)【後発医薬品メーカー】
(単位:品目)
平成 28 年度
(n=182)
平成 27 年度
(n=178)
平成 26 年度
(n=175)
薬価収載後 5 年以内の後発医薬品のうち供給停止した
品目数(合計値) 12 2 2
うち、供給停止 3 か月前までにすべての納入先
保険医療機関等に直接お知らせできた品目数
(合計値)
12 - -
うち、保険医療機関等に代替品等の情報を提供
した品目数(合計値) 12 - -
図表 1- 76 薬価収載後 5年以内の後発医薬品のうち供給停止した品目名と
その理由(平成 28 年度)【後発医薬品メーカー】
品目名
自社の売
上高に占
めるシェア
供給停止した理由
ロサルタンカリウム錠25mg「本草」 0.01% 他社製品が多数あったため
ロサルタンカリウム錠50mg「本草」 0.35%
ロサルタンカリウム錠100mg「本草」 0.00%
ドセタキセル点滴静注液20mg/1mL「ファイザー」 0.00% 業務提携先の事業統合に伴う重複品目整
理のため ドセタキセル点滴静注液80mg/4mL「ファイザー」 0.00%
オキサリプラチン点滴静注液50mg/10mL「ファイザー」 0.09%
オキサリプラチン点滴静注液100mg/20mL「ファイザー」 0.31%
オキサリプラチン点滴静注液200mg/40mL「ファイザー」 0.03%
エピルビシン塩酸塩注射液50mg/25mL「ホスピーラ」 0.00% 会社の合併に伴う重複品目整理のため
エピルビシン塩酸塩注射液10mg/5mL「ホスピーラ」 0.00%
ゲムシタビン点滴静注用200mg「ファイザー」 0.00%
ゲムシタビン点滴静注用1g「ファイザー」 0.00%
58
59
5
� 28 207 3
185
� 5 13
� 5
59
60
1
� 3.5 3.0
� 25 26 27
60
61
2 80%
� 80
19.9 37
11.3 21
4.3 8 61.8 115
61
62
�
�
� 2
�
�
�
� OS
�
�
�
62
63
3 32 9
� 78.5 146
� 32 9
41.8 61 34.9 51
22.6 33
�
95.1 8.2
26 27 33 3
26 27 11 27 28 11 2829 11
63
64
�
64.7
26 27
1 26 27 226 28
33
64
65
�
21.6 8 37.8 14 37.8 14
4
�
75.0
72.3
�
85.1
84.2
65
66
2
66
67
67
68
68
69
69
70
5
� 3,991 40.7
� 27 2.8
70
71
6
�
10,109 82.2
� 27 15.0
26 27 11 27 28 11 2829 11
26 27 11 27 28 11 2829 11
26 27 11 27 28 11 2829 11
71
72
�
5,919 47.9
� 27 23.3
26 27 11 27 28 11 2829 11
26 27 11 27 28 11 2829 11
26 27 11 27 28 11 2829 11
72
73
7
� 28 3,793
8,829,768,552
73
74
�
�
� MF
�
�
�
�
�
�
� GMP
� FDA PMDA GMP
�
�
�
�
�
�
�
74
75
�
�
�
�
�
�
� 80
�
�
�
�
75
76
1
� 2.7 5
2
�
1 1
76
77
�
3.0
3
� 5
0
77
78
1
�
65.2 120
78
79
2
�
3.3 4
79
80
3
� 4
6 5
1
25
4
�
�
�
�
� AG GMP
�
�
� GVP
GVP
�
�
�
80
81
1
�
70.1 129
81
82
2
�
2,489 49.3
�
670 82.4
� 27
82
83
83
84
�
�
�
�
�
� 1 2 1
�
�
�
�
�
� 29
�
�
�
�
�
�
84
85
�
� ICH
� PIC/S
�
�
�
MF � MF
�
� MF
�
�
85
86
1
�
30.4 56
28.3 52 40.8 75
� 27
86
87
�
65.4
46.2 36.5
87
88
2
�
�
� MR
� MR
�
�
�
�
3
�
19.9 37
78.5 146
88
89
�
�
�
�
�
� MR
�
4
�
25.3 47 72.0 134
� 27 3.0 5
� 51.1
46.8
89
90
90
91 91
92
�
�
�
�
�
�
�
�
�
�
�
�
92
93
1 100
� 100
85.3 157
93
94
2
�
2 30.4 56 3 4
42.4 78
� 27 2 5.1
9
Fax 1 3 MR
94
95
95
96
3
� 29 1 3 3 618
1
608
4
�
54.9 101
� 27 6.3 12
96
97
97
98
5
� 28 34.7 35
6
�
29 10 30 3 30 4 30 9 25.0 3
98
99
7
�
77.9
� MR
MR
DSU
99
100
100
101
MS
1 MS
� MS
42.4 78 15.2 28
24.5 45 16.3 30
� 27
25
MRMS
101
102
102
103
2 MS
� MS
� GVP
� MR MS
� MR MS
� MR MS
� MS
� MS
�
� MS
�
� MR MS
� MS
�
�
�
�
�
� MR
103
104
� 24
�
� MR MS
�
�
�
104
105
1
�
20.1 37 78.3 144
105
106
26 20,000 1
2
�
�
�
�
�
�
�
�
�
106
107
�
�
�
�
1
� 70.1 129
28.8 53
25 188
67 121
107
108
108
109
�
52.7 51.2
50.4
� 27
7.7
109
110
� 37.2 48
45.0 58 8
�
�
�
� MR
�
�
110
111
1
� 661
44.7
� 27
� 652 44.1
�
44.4 41.1
34.4
111
112
112
113
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
� CM
�
113
114
�
� 1
� MR MR
�
114
115
� 32 9 80
�
�
�
� 80
�
�
�
�
� 80
�
5 6
7
�
�
�
115
116
�
�
�
� G1
�
�
� BCP
116
117
23
47
29 12 15 30 1 23
47 47 100.0%
117
118
� 28 83.0 39
� 8
118
119
1
2 0
3
27
4 28
27 28
119
120
1
2 0
3
27
120
121
� 28 8
5 2
1
30
30 3
12
121
122
1
1 28
23
122
123
2
� 3.4 1.4
� 12.6
12
12
3 28 23 52 2 1 1 1
1 57
123
124
124
125
3
� 64.1 25
25 26 27
1
2
125
126
4
� 15.4 6
126
127
5
� 35.9 14
6
127
128
7
� 79.5
31 27 10
8
�
� 157 970
�
�
�
�
�
�
�
�
188 114 40
�
128
129
�
�
12
9
� 46.2 18
129
130
10
� 83.3 15
27.8 5
12
28
11
� 41.0 16
27 11
1
2 26
130
131
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
12
131
132
�
�
�
�
�
�
�
�
�
�
�
�
132
133
� 20.5 8
2.6 1 76.9
30
1
2 23 27 1 26 4 282 28
3 30 1 28
133
134
�
�
�
�
� 1
� 80
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
� A H23 H24 B H25 H26
134
135
�
� 75.0 6
12.5 1 12.5 1
1
2
135
136
�
�
�
�
�
�
�
�
�
136
137
�
�
�
�
�
�
�
137
138
�
25.5 12
28
�
8.5 4 29
12.8 6 78.7 37
28
138
139
� 42.6 20
27 2
PDCA
139
140
1
� 34.0
16 27
2
1
2
140
141
3
� 53.2 25
27 10
4
1
2
141
142
5
�
55.3 26
28
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
142
143
�
�
�
�
� 740 433
�
�
�
�
�
�
�
�
�
�
� 28
�
�
�
�
�
�
�
�
�
143
144
6
�
17.0 8 27
3
�
�
�
�
�
�
�
�
144
145
� 28
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
145
146
7
�
53.2
� 25.5
12.8
146
147
8
�
14.9 7 27 2
�
�
�
�
�
�
147
148
�
�
� DPC
�
�
�
�
�
� 28
�
�
�
� H29
�
�
�
�
�
�
�
�
�
148
149
9
� 57.4 27
27
27
149
150
10
�
10.6 5
12 263 28
50mg 3mgL250 250
10 30mg 90mg
5
150
151
�
�
�
�
�
�
�
�
�
� H27.11
�
�
�
�
� 30
�
�
�
151
152
�
�
�
�
�
�
�
�
�
�
� 29 5 71.7 69.0
32 9 80
�
�
7 73.2
29 4 7 28 71.6 1.6
�
� 2018 7 72.8
2020 32 9 80
�
�
152
153
� 24 29 2 72
10
�
� 29 7
�
� 80
�
�
� MEDIAS
�
29 5
68.2 69.0
�
�
�
�
�
153
154
�
�
�
�
� 63.6 45 29 5
�
�
�
�
�
� 29 32 9 80
154
155
�
14.9 7
28
28
28
155
156
28
28
156
157
�
17.0 8
� 80
44
� A
A
� B
29 9
�
� 23 22
23 8
�
�
�
�
157
158
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
GE
�
� MR
80
�
�
158
159
�
GE
32 9 80
�
�
�
�
�
�
�
�
�
�
�
�
159
160
� PR
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
�
160
161
�
�
�
�
�
�
�
80
�
�
�
�
�
�
�
�
161
162
�
�
�
162
163
� 23
� 23
�
� 30 1 23 2
� 29 12 15 30 3 2
23 23 100.0%
163
164
�
100.0 23 30.4 7 17.4 4
164
165
1
� 100.0 23
165
166
2
� 25 39.1 9
26 34.8 8
3
� 95.7 22
4.3 1
166
167
4
� 65.2 15
47.8 11
5
� 29 4 29 12 9
167
168
6
�
168
169
7
�
�
�
�
�
� 3 15
�
�
�
� 25 27 28
�
�
169
170
1
�
73.9 17 69.6
16 52.2 12
� 1
� 4
�
� 28 28 2 6,900
�
�
28
�
� 10
170
171
� A
� 29 8 9 30 2 3
29 8 4,200 29 9 1,800
�
�
�
�
� 28 B 29
�
� 2 1
�
�
�
�
29
�
�
�
� 2 1
�
�
� 6
�
171
172
�
�
�
� 29 30,000
�
�
�
�
� 1
�
�
� 50
� C C
�
�
25
�
� 1
�
172
173
2
�
� 2 1
�
5
� 5
1
30 2 9
�
25
60,000
60,000
Q&A 11
� 13
� 18
� 2212
173
174
� 8.7 2 91.3 21
2 1
�
174
175
1
� 4.8 1
95.2 20
175
176
2
� 81.0 17 14.3
3
176
177
3
�
�
�
�
�
�
�
�
�
177
178
� 80
�
�
� PR
�
�
�
�
� PR
�
�
�
�
�
� 3
HP
� HP
178
179
�
�
� PR
� PR
�
�
�
� PR
�
�
�
�
�
�
�
�
�
179
180
�
�
�
�
� PR CM
�
�
�
�
�
�
� 30 PR
�
�
�
�
�
180
181
�
�
�
80
�
�
�
�
�
�
�
�
�
�
�
�
�
�
181
182
28
3
1,500
2,000
2,500
29 12 18 30 1 31
1,500 491 32.7%
2,000 516 25.8%
2,500 1,234 49.4%
182
183
1
2
183
184
3
4 DPC
184
185
5
185
186
6
186
187
7
1 42 28 271 2 2
3
187
188
8
3
3
9
188
189
10
1 1 2
189
190
190
191
1
2
191
192
192
193
3
193
194
4
1 42 28 271 2 2
3
5
194
195
6
1 1 2
195
196
196
197
7
2
197
198
8
198
199
1
�
34.6 36.2
199
200
2
�
19.6 40.3
7
200
201
201
202
202
203
3 2
203
204
204
205
205
206
206
207
207
208
3
3
208
209
1
209
210
29 3 1
29 3 1
210
211
�
89.0 83.7
�
24.6 24.4
�
58.8 45.0
� 35.8
30.8
�
80.6 78.4
�
�
29.0 22.1
211
212
5 AG 54 2
212
213
213
214
AG 14 4
4
214
215
215
216
216
217
217
218
� 89.8
9.8
�
58.9 7.5 3 2
218
219
�
MR 84.1 MS 67.8
� PMDA 26.1 28
41.5 4
� MR
32.2 MS 23.2
3 8.2
� MS
54.0 MR 49.3
� 6.2 PMDA
3.3
� MS
34.4 MR 28.8
�
MS 81.0 MR
72.6 27
� 32.5 3
� MS
38.5 MR 26.4
3 13.0
219
220
7 5 SAFE DI
5
220
221
221
222
2 2
2
222
223
223
224
224
225
225
226
1
� 28 221.5
24.3
� 26.9 21.3 22.0
� 1.3 1.0
226
227
2
� 28 45.0
28.7
� 31.4 25.5 18.0
227
228
3
� 28 342.0
32.0 27
3.5
� 34.0 25.5 7.5
� 0.3 0.0
228
229
229
230
1
� 28 41.1
10.9 27.7
� 27 9.0
3.6 4.2
230
231
2
� 28
388
31 641 1
2.2 2.4 2.1
� 89
22.9 5 16.1 177 27.6
267 68.8 24
77.4 440 68.6
� 29 7.5
11 35.5 90 14.0 27
� 3
75 19.3 2 6.5 144 22.5
27
�
247 63.7 17 54.8 373 58.2
27
231
232
3
� 28
�
232
233
4
�
�
5
4 3 2
233
234
11 2
234
235
1
� 28 17.7
2.4 20.8
� 27 1.6
0.4 1.5
2 3 42 5 5 6
235
236
2
� 28
176
22 515 1
2.6 7.3 2.5
� 17 9.7 0
0.0 68 13.2
45 25.6 3 13.6 228 44.3
� 27 4.7
236
237
3
�
27
� 1.1 27
8.9 27 2.1
237
238
4
� 28
27
0.5
6.1
238
239
5
�
239
240
2 2
2
240
241
� 13.4 0.9
4.5
241
242
12
11
10
8
7
7
2
2
2 1
242
243
12
7
4
4
3
3
A B
243
244
�
1
� 2 3
6 27
244
245
�
62.5 56.4
54.6 5
� 43.1
32.2
� 83.0 8
9 8
5
245
246
55
246
247
�
51.3 35.1 43.6
247
248
� 14.7 13.3
27.4
� 27 2.0
2.1
248
249
� 66.4
36.5 79.2
249
250
� 87.0
82.5
65.0
�
42.1 22.3
�
51.7 49.6
47.5
�
24.4 17.6
� 81.7
75.6
� 32.1
30.1
250
251
5
3 2
251
252
3 AG
3
252
253
9 AG 3
2 2
253
254
26
26
254
255
255
256
256
257
� MR
71.1 68.9
�
257
258
� 7.5
4.1 3.6
258
259
8
5
5
4
3
3
3
4
2
2
2
6
5
3
3
259
260
�
73.5 68.0
67.2 60.1
6
� 73.4 49.6
45.2
� 60.9
57.5 56.0
16 10
7 3 33
260
261
4 2
2 2
19 12
11 5 8 4
261
262
1
�
55.4 20.1 34.5
� 27
262
263
�
26.1 26.0 18.6
263
264
2
�
53.3 15.7 43.6
�
19.5 23.5 16.5
264
265
3
�
41.9 10.5 32.6
� 27 10.0 11.5
265
266
�
28.2 29.6 23.1
� 27
266
267
4
�
27.7 6.6 20.0
267
268
�
22.1 17.6
28.0
� 27 7.1 8.0
268
269
5
�
33.4
16.3 37.3
� 27 2.8 6.3
269
270
�
23.8 20.7
270
271
�
72.1 22.1 56.0
� 27
271
272
�
35.6 10.1 20.8
� 61.9 84.5 76.3
272
273
� 29 6 9 32
9 80
88.4 45.0 91.0
26 27 29 6 9
273
274
�
4
3
4
2
2
3
2
15
4
4
274
275
2
2
3
2
2
2
5
2
275
276
6
2
6
4
3
276
277
5
CM
PR
46
277
278
�
1
1
5
1 20
5
AG
1 30
5 10
278
279
279
280
80
TV
200 200
280
281
DPC
1
DPC
281
282
1 1
80
282
283
AG
AG
283
284
1
1 20 30
1 10
5
PR
CM
284
285
80
285
286
9
PR
80
1
286
287
AG
287
288
�
2 3 1
1
MR
MR
288
289
OD 56 90
OD
1 1
289
290
AG
AG
MR
MR
290
291
AG
M A
AMPC
2 3
3 4
291
292
MR
292
293
OD
PTP
PTP
CM
CM
CM
293
294
CM GE
AG
1
+
294
295
�
295
296
MR
OD
ARB
1
20 30 5 6
296
297
1 10
No.1 No.6 1
297
298
MR
MR
298
299
AG
299
300
10 7
1
A A
1
300
301
AG
MR
301
302
1
1 1
1 4 5
20 30
OD
OD
302
303
TV
60 80
1
5
303
304
80
AG
AG
AG
1
100 30 14
304
305
1 2 1 2 75
75
1
3 80
41
AG 2
305
306
AG
AG
FAX
306
307
307
308
308
309
2
2
29 12 14 30 3 26
309
310
1
28 8 2 2 610
235 20 600
100 2 50
1 2 8 3 4 2 9
10
28 25.0 29 1 27.4
25
270 6.1
310
311
2
28 27
9
7 758
85
20
7 15
4 500
1 2 3 1
1
758
758
311
312
758
758
758
3
312
313
758
3
4
28 1 6 30
30 2 12 15 20 50
1 1 283 2 368
1 2
28
27 HIV
28
313
314
HIV
28
29 1 6 29 30 2 12 18 25
55 1 1 300
2 80 300 81 470
29 2
1 28 2 3
29 1 2
6 12
6
1
30 1 6 8 2 12 2 3
3
314
315
36.4% 41.3% 45.7%55.6% 58.9% 59.9% 61.6%
0102030405060708090
100
25 4 26 5 27 4 28 3 28 8 29 2 29 8
[%]
315
316
1
70%9
65.069.91460.0
64.9%20
55.059.9%
15
50.054.9%3
40%1
316
317
128 1,600
227 4
462
3
26
2 1
28
29
43,726
116,589
208,706
336,627
40,548
72,708
130,335
154,897
0
30,000
60,000
90,000
120,000
150,000
180,000
050,000
100,000150,000200,000250,000300,000350,000400,000
25 26 27 28
1
[ ][ )
317
318
30
1Q&A
Q&A 28 297,500
227 4
475
3
1,537,525
316,751
1,672,576
0
300,000
600,000
900,000
1,200,000
1,500,000
1,800,000
26 27 28[ ] [ ]
318
319
1
228 6
6
329
19 2
1
CM
2
32 6
Q&A
319
320
1
28 3,500 10,000
2
29 4
2016 6
1
320
321
2
70 72.0
66.1
30 Z2
CM
380
1
321
322
1
29 100
1
1
10
5
322
323
2
MS
OD
3MS
40 7,000
AG AG
10 10
323
324
1
28 5 10 5
4
1
28 61
17 6 5
28
MS
140 100
5 AG
MR MR
324
325
AG
AG
MR
2
MS MR
PR MR MS
1 35 5
MR
MS MR
MR MR
MR
MR
3
29 9
10.6 42.2
31.8 6.5
325
326
28 5 29 9 9
0.6 0.7
70 80
MR
3
MR
MR
6
326
327
1
28 533 394 84 55
28
3
MR
MS
28 110
55 41 14
3
327
328
3
1
128 7
7
1 20
1 5
2
QR
328
329
3
G1
1
28 381 88 86
555 Ca 27
26 25 24
5 128
A B
28 42 6 5
53 9
6 6 5
329
330
MS
28 142
MR 5 6
2
MS
PTP
MR
330
331
3
1
1
50 10
331
332
1
25 26 3 6 4 25
Q&A
29 3 6
GE
GQP
332
333
2
26 7 22
GE GE
PMDA
333
334
3
28 GE
GE
4
GE
GE
GE
5
334
335
1
80
GE
26
27
28
27 10 20 PMDA
27 19 28 10 29 12
12 15 44
24 7 GE 28 1
9 1 5 3
5
335
336
28
80
2020 9
29 80
2
28 89 47 42
GE
336
337
11 16 27 14 28
25 28 10 28
GE
3
28 GE
3 28
28
28
4
WEB
337
338
30 2 18
14
GE
29
29 9 42 41
1
28
338
339
1
1
2
2
1 1
1
2 1
1
1
1
1
1
1
2 1
1
339
340
1
29
29 12
2 3
GMP
340
341
2
AG
3
PTP
50 10 40
32
341
342
1
50
24
342
343
MS
2
MS
MS 2010 29 11 1,075
MS
1 6
MS 1
MS
343
344
3
1 2
R
2 6
84
344
345
345
346
346
347
26 4
IQVIA IMS Health Quintiles Quintiles IMS IQVIA MIDAS
24 8 22
3
12
22017 2016 10 2017 9 2018 1
33
27
347
348
MIDAS
2015 27 4 MIDAS
2 EARLY ENTRY GENERIC PRODUCTS
BIO-COMPARABLE PRODUCTS”
27 2014 2013 10 2014 9
2015 2014 10 2015 9
2014
MIDAS 2015 2014 10
2015 9
Copyright © 2018 IQVIA
GENERICPRODUCTS
NON-GENERICPRODUCTS
NEVERPROTECTED
NO LONGERPROTECTED
NEVERPROTECTED
NO LONGERPROTECTEDPROTECTED
ANY OTHERCOMBINATION
NEVERPROTECTED
EARLY ENTRY GENERIC PRODUCTS
PROTECTED
BIO-COMPARABLEPRODUCTS
LAUNCHED UNDER ANY BIOSIMILAR
APROVALPATHWAY
NON-CATEGORISEDPRODUCTS
OTHERPRODUCTS
348
349
GENERIC PRODUCTS NEVER PROTECTED NO LONGER PROTECTED
GENERIC PRODUCTS IQVIA
EARLY ENTRY GENERIC PRODUCTS
PROTECTED
BIO-COMPARABLE PRODUCTS LAUNCHED UNDER ANY BIOSIMILARAPPROVAL PATHWAY
NON-GENERIC PRODUCTS NO LONGER PROTECTED
IQVIA
PROTECTED
NON GENERIC PRODUCTS PROTECTED
Copyright © 2018 IQVIA
IQVIA MIDAS
MIDAS
2013 25 2013 4
2014 3 70.9 2014 26 73.1 2015 27
76.7 2016 28 80.5
MIDAS IQVIA Standard Units SU
SU IQVIA
1SU 1 1
1 5ml 0.1ml 0.05ml
SU IQVIA
349
350
26 IQVIA
IQVIA
IQVIA
350
351
IQVIA MIDAS
GENERIC PRODUCTS
EARLY ENTRY GENERIC PRODUCTS
BIO-COMPARABLE PRODUCTSNON-GENERIC PRODUCTS
IQVIA, MIDAS, Market Segmentation, MAT Sep 2017, RX only PRESCRIPTION BOUNDSU IQVIA MIDAS data
IQVIA2016.4 2017.3 80.5
100Copyright © 2018IQVIA, MIDAS, Market Segmentation, MAT Sep 2017, RX only PRESCRIPTION BOUND
92.3%
61.9%
86.8%77.1%
58.9%68.0% 64.3%
7.7%
38.1%
13.2%22.9%
41.1%32.0% 35.7%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
351
352
GENERIC PRODUCTS
EARLY ENTRY GENERIC PRODUCTS
BIO-COMPARABLE PRODUCTSNON-GENERIC PRODUCTS
IQVIA, MIDAS, Market Segmentation, MAT Sep 2016, RX only PRESCRIPTION BOUNDLCD IQVIA MIDAS data
IQVIA2016.4 2017.3 80.5
100Copyright © 2018IQVIA, MIDAS, Market Segmentation, MAT Sep 2017, RX only PRESCRIPTION BOUND
52.0%
32.4%
53.5% 54.1%40.6%
49.2% 43.9%
48.0%
67.6%
46.5% 45.9%59.4%
50.8% 56.1%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
352
353 353
354
354
355
GEN
ERIC
PR
OD
UC
TSEA
RLY
EN
TRY
GEN
ERIC
PR
OD
UC
TS
BIO
-CO
MPA
RA
BLE
PR
OD
UC
TSN
ON
-GEN
ERIC
PR
OD
UC
TS 2013
.10
2014
.920
14IQ
VIA
, MID
AS,
Mar
ket S
egm
enta
tion,
MAT
Sep
201
4, R
X o
nly
PRES
CR
IPTI
ON
BO
UN
DSU
IQV
IA M
IDA
S da
taIQ
VIA
2013
.420
14.3
70.9
2015
IQV
IA, M
IDA
S, M
arke
t Seg
men
tatio
n, M
AT S
ep 2
015,
RX
onl
yPR
ESC
RIP
TIO
N B
OU
ND
SUIQ
VIA
MID
AS
data
IQV
IA20
14.4
2015
.373
.120
16IQ
VIA
, MID
AS,
Mar
ket S
egm
enta
tion,
MAT
Sep
201
6, R
X o
nly
PRES
CR
IPTI
ON
BO
UN
DSU
IQV
IA M
IDA
S da
taIQ
VIA
2015
.420
16.3
76.7
2017
IQV
IA, M
IDA
S, M
arke
t Seg
men
tatio
n, M
AT S
ep 2
017,
RX
onl
yPR
ESC
RIP
TIO
N B
OU
ND
SUIQ
VIA
MID
AS
data
IQV
IA20
16.4
2017
.380
.510
0C
opyr
ight
© 2
018I
QV
IA, M
IDA
S, M
arke
t Seg
men
tatio
n, M
AT S
ep 2
017,
RX
onl
yPR
ESC
RIP
TIO
N B
OU
ND
355
356
356
357
GEN
ERIC
PR
OD
UC
TSEA
RLY
EN
TRY
GEN
ERIC
PR
OD
UC
TS
BIO
-CO
MPA
RA
BLE
PR
OD
UC
TSN
ON
-GEN
ERIC
PR
OD
UC
TS 2013
.10
2014
.920
14IQ
VIA
, MID
AS,
Mar
ket S
egm
enta
tion,
MAT
Sep
201
4, R
X o
nly
PRES
CR
IPTI
ON
BO
UN
DLC
DIQ
VIA
MID
AS
data
IQV
IA20
13.4
2014
.370
.9
2015
IQV
IA, M
IDA
S, M
arke
t Seg
men
tatio
n, M
AT S
ep 2
015,
RX
onl
yPR
ESC
RIP
TIO
N B
OU
ND
LCD
IQV
IA M
IDA
S da
taIQ
VIA
2014
.420
15.3
73.1
2016
IQV
IA, M
IDA
S, M
arke
t Seg
men
tatio
n, M
AT S
ep 2
016,
RX
onl
yPR
ESC
RIP
TIO
N B
OU
ND
LCD
IQV
IA M
IDA
S da
taIQ
VIA
2015
.420
16.3
76.7
2017
IQV
IA, M
IDA
S, M
arke
t Seg
men
tatio
n, M
AT S
ep 2
017,
RX
onl
yPR
ESC
RIP
TIO
N B
OU
ND
SUIQ
VIA
MID
AS
data
IQV
IA20
16.4
2017
.380
.520
1420
1520
161
2016
2017
120
1720
181
100
Cop
yrig
ht ©
201
8IQ
VIA
, MID
AS,
Mar
ket S
egm
enta
tion,
MAT
Sep
201
7, R
X o
nly
PRES
CR
IPTI
ON
BO
UN
D
357
358
358
359
359
360
360
361
5
28
25
18 3 10
26
28
29
25
361
362
28
28 6 16 12 8
34
29
29 6 15 12 7
13
28
28
UFJ
29
29
UFJ
28
32
27
29
24
25
362
363
25 28
28 2
28 34
28 17.7 2.4
20.8
37.9
22.4 27.6 3.8
1.1 15.8
8.9 2.1
14.3
363
364
28
5.5 5.2
364
365
95
25
26
25
27
6025
365
366
29
29 11 1
23 100.0
25
26 3
29
186 151 81.2
101 57 56.4
41 100
34
28
29 3 6
148
290
28
26
1 27
27 12 9 10 8
27 11 20
366
367
28
29 11
186 156 83.9 26 14.0
86.6 100.0
186 177
95.2 96.5
100.0
2 3 4 2 5 5
6
28 184 146 79.3
35 19.0 1
0.5
28 10 21
181 5.5
28 5 5
96 5.2
28 17.7 2.4
20.8
25.6 13.6 44.3
9.7 0.0 13.2
21 15 71.4
5 3 60.0
24.1 20.0 14.0
367
368
29 11 80
186 37 19.9 21
11.3
186 123 66.1
174 3.5 3.0 29
3
28
41.1 10.9
27.7
28
13.4 4.5
1 2.3 2.1
135 125 92.6
77 70 90.9
100.0
29 11 1
23 692
25 28
34
368
369
28 21
5
25
28.6 26 32.9 27 37.9 28 40.7
369
370
80
1
370
371
25
28
28 9 7 29 3 3
No.6 28 6 No.7 28 12
PMDA
28 WG
29 3 31
29
29 8 28 30 3 14
No.8 29 5 No.9 30 1
PMDA
28
371
372
30 2 200
28
28 890 52
29
29
28
5
28 PMDA 77
29
5
55.4 20.1 34.5
53.3 15.7 43.6
372
373
28
47 39 83.0 28 8
28 39
6 15.4
14 35.9
31 79.5
10
28
39 18 46.2 21
53.8 18
5 27.8
28 39 28
8
373
374
28
25
25
374
375
28
28 89 47 42
184 120 65.2
63 34.2
28
4 27 3
28
12 6
6
184 129
70.1 29 3
41 40 97.6
5,046 2,489
813 670 29 3
49.3 82.4
1
3.0 2
375
376
7
34.6 35.4
5
87.4 53.9 50.3 48.5 44.3
36.5
83.3 32.3 30.2 30.2 29.2
28.1
376
377
1.26 1.48
5
5.70 0.97 0.68 0.67
0.66 0.59
5.86 0.88 0.70 0.55
0.51 0.51
PMDA
25
24
28 39
8 20.5
1 2.6 30 76.9
377
378
28 47 27 57.4
27 14 51.9
13 48.1 8 29.6
8 8
80
80
23
378
379
26
25
25MR
100
124
MS MR MS
25
28
25
web
3 28
28
28
379
380
100 184
157 85.3 9 4.9
59.9 37.2 42.1
56.2 51.7
44.0
29 1 3 618
1 608 98.4
184 101 54.9
12 6.5 47 25.5
16 8.7
MS 184 78 42.4
28 15.2 30 16.3
45 24.5
MR 7
73.5 68.0
67.2 60.1
73.4
60.9 57.5 56.0
MS
380
381
MS
2
Q&A
Q&A 25
25
2529
381
382
25
28
1 726
1 JR
11/23 16 2/12 17
29
1 1,629
28
28
UFJ
29
29
UFJ
28
TV 2016
382
383
CD
29
28
29
28
29
28
29
28
28 11 3 70
80
29
2
383
384
3 3
28
28 7
29
29 8
30
28
29
28
30
384
385
GE
385
386
25
25
25
25
25
25
28
47 39 83.0 28
8
386
387
29
28
39 35 89.7
28 39
6 15.4
14 35.9
31 79.5
10
28 39
8 20.5
1 2.6 30 76.9
28
39 18 46.2 21
53.8 18
5 27.8
47 8 17.0
47 7 14.9
387
388
28 39 28
8
28
80
80
23
388
389
25
28
28 WEB
29 3 184 129 70.1
29 3
1,478 661
26 1,268 28 652
51.3 35.1 43.6
34.2 30.3 36.6
3
389
390
97.6
28
44.7
390
391
28 610
270
27 758
28 50 1
3.4
23
28 1 2
28 1,600
27 4 462
2 1
28
167
23 17
391
392
25
25
25
28
28
392
393
29
28
29
28
28
28 28
29
28 29
393
394 394
全国健康保険協会作成 地域別ジェネリックカルテ(都道府県別) 平成29年10月版
【医療機関の視点】
院外処方ジェネリック医薬品使用割合
偏差値 指標数値影響度(※13)
01 北海道 56 71.0 53 61.6 + 0.3 39 74.3 - 0.1 52 58.7 + 0.1 54 61.0 + 0.2 55 20.1 56 73.3 + 1.6 58 73.4 + 0.8 54 73.2 + 0.8 45 43.9 56 73.3 + 1.6 58 83.6 55 79.9 59 15.1 55 60.1 62 + 2.4
02 青森 61 72.8 68 69.6 + 1.6 52 78.6 + 0.0 51 58.1 + 0.0 73 71.0 + 1.6 58 17.8 57 73.5 + 1.8 40 67.3 - 0.7 62 75.7 + 2.5 43 43.0 57 73.5 + 1.8 68 87.1 58 82.2 68 11.6 49 57.6 62 + 2.4
03 岩手 67 75.5 63 66.9 + 1.2 54 79.3 + 0.0 64 68.7 + 0.4 60 64.1 + 0.6 57 18.8 68 77.4 + 5.0 74 78.8 + 2.0 65 76.8 + 3.0 55 48.1 68 77.4 + 5.0 69 87.3 57 81.2 67 12.2 70 66.4 56 + 1.8
04 宮城 60 72.4 58 64.3 + 0.8 46 76.6 - 0.0 51 58.1 + 0.0 60 64.3 + 0.7 57 18.8 59 74.3 + 2.5 56 72.8 + 0.5 59 74.9 + 2.0 47 44.8 59 74.3 + 2.5 63 85.2 57 81.2 61 14.3 55 59.9 55 + 1.8
05 秋田 52 69.5 44 57.3 - 0.5 60 81.2 + 0.1 59 64.6 + 0.2 36 51.6 - 0.8 61 16.4 52 71.8 + 0.4 61 74.5 + 1.2 46 70.2 - 0.7 56 48.4 52 71.8 + 0.4 56 83.1 61 83.6 55 16.7 57 61.0 60 + 2.2
06 山形 61 72.8 66 68.3 + 1.9 59 80.8 + 0.1 60 65.5 + 0.2 66 67.4 + 1.5 52 22.5 58 74.2 + 2.2 58 73.5 + 0.7 58 74.4 + 1.5 60 50.4 58 74.2 + 2.2 58 83.7 52 77.5 52 17.8 63 63.2 40 + 0.3
07 福島 55 70.5 61 65.9 + 1.3 49 77.4 - 0.0 54 60.1 + 0.1 64 66.6 + 1.2 50 23.4 52 71.9 + 0.5 48 69.9 - 0.2 53 72.6 + 0.6 43 42.8 52 71.9 + 0.5 56 82.9 50 76.6 55 16.4 51 58.5 59 + 2.1
08 茨城 49 68.3 47 58.7 - 0.3 51 78.2 + 0.0 53 60.0 + 0.1 44 55.9 - 0.4 55 20.5 48 70.8 - 0.4 50 70.5 - 0.0 48 70.9 - 0.4 46 44.4 48 70.8 - 0.4 45 79.2 55 79.5 45 20.2 55 60.2 53 + 1.5
09 栃木 46 67.0 42 56.1 - 1.2 43 75.4 - 0.0 50 57.5 + 0.0 40 53.6 - 1.0 39 31.2 51 71.7 + 0.3 47 69.7 - 0.2 53 72.5 + 0.5 63 51.8 51 71.7 + 0.3 47 80.2 39 68.8 43 21.1 42 54.6 59 + 2.1
10 群馬 52 69.5 56 63.5 + 1.2 52 78.4 + 0.0 51 58.2 + 0.0 59 63.8 + 1.3 33 35.8 55 72.9 + 1.0 52 71.3 + 0.1 56 73.7 + 0.9 58 49.3 55 72.9 + 1.0 53 82.1 33 64.2 57 15.8 58 61.2 33 - 0.4
11 埼玉 53 69.7 49 59.7 - 0.1 47 76.7 - 0.0 54 60.3 + 0.1 47 57.6 - 0.2 57 19.0 52 72.0 + 0.6 53 71.7 + 0.3 52 72.2 + 0.3 53 47.4 52 72.0 + 0.6 52 81.6 57 81.0 54 17.0 57 61.0 52 + 1.4
12 千葉 53 70.0 52 61.4 + 0.2 57 80.1 + 0.0 61 66.5 + 0.4 46 56.9 - 0.3 57 18.7 52 71.9 + 0.5 51 71.0 + 0.1 52 72.3 + 0.4 45 43.9 52 71.9 + 0.5 48 80.5 57 81.3 45 20.1 57 61.1 56 + 1.8
13 東京 41 65.2 42 55.8 - 0.7 56 79.8 + 0.0 42 51.3 - 0.3 38 52.7 - 0.6 59 17.2 37 67.0 - 3.6 39 67.0 - 0.8 37 67.0 - 2.8 39 41.1 37 67.0 - 3.6 33 75.6 59 82.8 38 22.7 39 53.6 55 + 1.7
14 神奈川 50 68.6 48 59.4 - 0.1 58 80.7 + 0.0 58 63.8 + 0.2 39 53.2 - 0.5 65 13.3 46 70.0 - 1.2 53 71.7 + 0.2 44 69.3 - 1.5 50 45.9 46 70.0 - 1.2 42 78.4 65 86.7 46 20.0 56 60.6 59 + 2.1
15 新潟 54 70.1 36 52.8 - 1.3 32 71.7 - 0.1 23 35.8 - 1.6 57 62.9 + 0.3 57 19.1 57 73.8 + 2.1 45 68.9 - 0.4 62 75.8 + 2.5 62 51.1 57 73.8 + 2.1 62 85.0 57 80.9 54 17.1 48 57.2 57 + 1.9
16 富山 55 70.5 53 62.0 + 0.6 72 85.1 + 0.1 53 59.6 + 0.2 54 60.9 + 0.4 36 33.2 60 74.7 + 2.3 55 72.3 + 0.4 63 76.4 + 1.9 51 46.6 60 74.7 + 2.3 56 83.0 36 66.8 57 15.8 50 58.2 44 + 0.7
17 石川 51 69.2 52 61.5 + 0.4 46 76.4 - 0.0 51 58.3 + 0.1 53 60.6 + 0.4 39 31.1 54 72.7 + 1.0 52 71.3 + 0.2 57 74.0 + 0.9 51 46.5 54 72.7 + 1.0 47 80.1 39 68.9 59 15.2 61 62.5 50 + 1.3
18 福井 54 70.4 62 66.3 + 2.7 52 78.4 + 0.0 61 65.9 + 0.9 63 65.6 + 2.1 22 43.1 56 73.5 + 1.2 60 74.1 + 0.9 54 72.9 + 0.4 68 53.5 56 73.5 + 1.2 48 80.3 22 56.9 50 18.4 53 59.2 25 - 1.1
19 山梨 34 62.3 44 57.3 - 0.6 51 78.2 + 0.0 65 69.3 + 0.3 37 52.2 - 1.0 57 19.1 27 63.5 - 6.3 31 64.2 - 1.9 26 63.1 - 4.3 24 34.5 27 63.5 - 6.3 29 74.3 57 80.9 32 25.0 42 54.7 38 + 0.1
20 長野 56 71.0 50 60.3 + 0.0 62 81.9 + 0.1 48 55.5 - 0.1 50 59.0 + 0.0 51 22.8 59 74.2 + 2.3 59 73.7 + 0.9 58 74.6 + 1.4 50 46.1 59 74.2 + 2.3 55 82.8 51 77.2 59 14.9 55 60.2 49 + 1.2
21 岐阜 46 67.0 46 58.2 - 0.5 41 74.9 - 0.1 36 46.5 - 0.7 53 60.6 + 0.3 45 26.9 47 70.2 - 0.8 44 68.6 - 0.4 48 70.8 - 0.4 59 49.8 47 70.2 - 0.8 48 80.4 45 73.1 40 22.1 43 55.3 59 + 2.1
22 静岡 52 69.5 47 58.6 - 0.4 47 76.7 - 0.0 51 58.4 + 0.1 45 56.2 - 0.4 53 21.7 53 72.5 + 0.9 51 70.9 + 0.0 54 72.9 + 0.8 60 50.1 53 72.5 + 0.9 53 82.0 53 78.3 32 25.2 54 59.5 52 + 1.5
23 愛知 48 67.9 46 57.9 - 0.7 47 77.0 - 0.0 48 55.5 - 0.1 46 57.0 - 0.4 42 29.2 52 71.9 + 0.4 52 71.5 + 0.1 51 72.0 + 0.2 62 50.9 52 71.9 + 0.4 50 81.0 42 70.8 45 20.1 42 54.7 58 + 2.0
24 三重 48 68.0 47 58.5 - 0.5 42 75.2 - 0.0 41 50.6 - 0.4 51 59.3 + 0.1 41 29.8 52 72.1 + 0.6 51 70.8 + 0.0 53 72.6 + 0.5 57 49.1 52 72.1 + 0.6 56 83.1 41 70.2 54 16.9 49 57.6 50 + 1.3
25 滋賀 54 70.4 58 64.5 + 0.9 53 78.8 + 0.0 63 67.4 + 0.2 57 62.7 + 0.6 52 22.1 52 72.1 + 0.6 48 69.8 - 0.2 54 73.2 + 0.8 41 41.9 52 72.1 + 0.6 54 82.4 52 77.9 53 17.4 41 54.3 64 + 2.6
26 京都 39 64.6 46 58.2 - 0.7 42 75.2 - 0.1 44 52.8 - 0.2 48 57.9 - 0.3 35 34.3 40 68.1 - 2.1 40 67.1 - 1.0 42 68.7 - 1.1 32 38.3 40 68.1 - 2.1 40 77.6 35 65.7 39 22.6 43 55.3 54 + 1.6
27 大阪 41 65.2 47 58.7 - 0.5 54 79.3 + 0.0 46 53.8 - 0.2 48 58.1 - 0.2 41 29.8 40 68.0 - 2.3 42 68.0 - 0.5 40 67.9 - 1.8 44 43.4 40 68.0 - 2.3 36 76.3 41 70.2 38 23.0 38 53.1 49 + 1.2
28 兵庫 49 68.5 53 61.6 + 0.3 58 80.6 + 0.1 58 63.8 + 0.3 49 58.5 - 0.1 51 22.9 47 70.5 - 0.7 50 70.7 + 0.0 46 70.3 - 0.7 45 43.6 47 70.5 - 0.7 44 79.1 51 77.1 36 23.5 47 56.7 58 + 2.0
29 奈良 36 63.1 28 48.7 - 4.1 23 68.8 - 0.2 22 35.2 - 2.6 40 54.0 - 1.1 31 37.1 50 71.2 - 0.1 52 71.3 + 0.1 49 71.0 - 0.2 51 46.3 50 71.2 - 0.1 46 79.6 31 62.9 38 22.8 26 47.9 64 + 2.5
30 和歌山 39 64.3 45 57.6 - 1.0 42 75.2 - 0.0 50 57.5 + 0.0 46 56.7 - 0.7 29 38.3 42 68.7 - 1.6 34 65.0 - 1.2 47 70.5 - 0.4 43 42.8 42 68.7 - 1.6 47 79.9 29 61.7 51 18.0 41 54.2 61 + 2.3
31 鳥取 55 70.7 55 62.8 + 0.7 64 82.3 + 0.1 56 62.2 + 0.2 54 60.9 + 0.4 46 26.7 57 73.6 + 1.7 53 71.8 + 0.3 59 74.7 + 1.4 46 44.2 57 73.6 + 1.7 62 85.0 46 73.3 53 17.4 50 58.1 37 + 0.1
32 島根 58 71.8 61 66.2 + 1.3 65 82.8 + 0.1 54 60.8 + 0.1 61 64.8 + 1.0 53 21.8 56 73.4 + 1.6 59 73.7 + 0.7 55 73.2 + 0.9 40 41.8 56 73.4 + 1.6 63 85.2 53 78.2 66 12.3 58 61.4 31 - 0.5
33 岡山 45 66.9 47 58.6 - 0.5 51 78.2 + 0.0 46 54.0 - 0.4 50 59.1 + 0.0 32 36.1 50 71.2 - 0.1 51 70.8 + 0.0 49 71.4 - 0.1 65 52.5 50 71.2 - 0.1 49 80.6 32 63.9 55 16.7 43 55.3 31 - 0.6
34 広島 45 66.7 50 60.2 - 0.0 48 77.0 - 0.0 52 58.7 + 0.1 48 58.1 - 0.1 51 22.6 42 68.5 - 2.1 40 67.2 - 0.7 43 69.0 - 1.4 56 48.8 42 68.5 - 2.1 43 78.8 51 77.4 47 19.5 46 56.2 53 + 1.6
35 山口 54 70.1 53 61.7 + 0.3 48 77.1 - 0.0 60 65.6 + 0.4 49 58.4 - 0.1 51 23.1 54 72.6 + 1.0 47 69.7 - 0.2 56 73.8 + 1.2 52 46.7 54 72.6 + 1.0 58 83.6 51 76.9 63 13.6 55 60.1 53 + 1.5
36 徳島 21 57.4 29 49.3 - 3.9 34 72.4 - 0.1 40 49.1 - 0.9 28 47.4 - 2.6 33 35.7 22 62.0 - 6.0 21 60.6 - 2.1 25 62.6 - 3.8 33 38.7 22 62.0 - 6.0 34 75.8 33 64.3 39 22.5 20 45.5 34 - 0.2
37 香川 41 65.2 43 56.4 - 1.0 37 73.5 - 0.1 49 56.9 - 0.0 41 54.0 - 0.9 47 25.8 41 68.3 - 2.2 41 67.4 - 0.9 42 68.8 - 1.3 48 45.2 41 68.3 - 2.2 45 79.3 47 74.2 48 19.2 42 54.7 51 + 1.4
38 愛媛 40 64.8 40 55.0 - 1.9 39 74.2 - 0.1 43 51.9 - 0.5 41 54.3 - 1.2 32 35.8 48 70.5 - 0.5 53 71.8 + 0.3 44 69.5 - 0.8 44 43.3 48 70.5 - 0.5 61 84.8 32 64.2 55 16.6 50 58.1 38 + 0.2
39 高知 33 62.0 35 52.6 - 1.9 38 73.9 - 0.1 42 50.9 - 0.4 34 50.3 - 1.5 48 25.3 32 65.2 - 4.6 30 63.6 - 2.7 37 66.8 - 1.8 33 38.6 32 65.2 - 4.6 32 75.2 48 74.7 50 18.5 39 53.4 50 + 1.2
40 福岡 52 69.7 58 64.2 + 0.8 54 79.0 + 0.0 60 64.9 + 0.6 52 60.2 + 0.1 53 21.4 49 71.1 - 0.1 49 70.2 - 0.1 50 71.4 - 0.1 52 46.7 49 71.1 - 0.1 51 81.3 53 78.6 60 14.8 59 61.6 48 + 1.1
41 佐賀 58 72.0 54 62.5 + 0.3 47 76.8 - 0.0 42 51.4 - 0.2 57 62.7 + 0.3 62 15.7 57 73.6 + 2.0 49 70.1 - 0.1 60 75.3 + 2.1 63 51.6 57 73.6 + 2.0 57 83.4 62 84.3 56 16.1 57 61.0 59 + 2.1
42 長崎 55 70.9 61 65.9 + 1.3 50 77.8 - 0.0 57 63.1 + 0.3 61 64.7 + 0.9 51 22.9 53 72.4 + 0.8 57 73.2 + 0.7 51 71.9 + 0.2 37 40.2 53 72.4 + 0.8 60 84.2 51 77.1 61 14.3 58 61.5 54 + 1.6
43 熊本 54 70.2 59 65.0 + 1.4 52 78.6 + 0.0 59 64.2 + 0.5 59 63.6 + 0.9 42 29.1 53 72.4 + 0.7 50 70.5 - 0.0 54 73.1 + 0.8 62 51.1 53 72.4 + 0.7 54 82.3 42 70.9 59 15.0 59 61.6 46 + 0.9
44 大分 47 67.7 53 61.9 + 0.4 37 73.7 - 0.1 45 53.2 - 0.2 58 63.2 + 0.7 48 25.1 45 69.6 - 1.3 46 69.3 - 0.4 45 69.7 - 0.9 46 44.1 45 69.6 - 1.3 48 80.5 48 74.9 48 19.0 39 53.6 29 - 0.7
45 宮崎 59 72.2 50 60.4 + 0.0 39 74.1 - 0.1 50 57.5 + 0.0 51 59.4 + 0.0 55 20.5 61 75.1 + 3.0 58 73.3 + 0.6 62 75.7 + 2.4 49 45.5 61 75.1 + 3.0 67 86.6 55 79.5 66 12.7 53 59.2 43 + 0.6
46 鹿児島 68 75.9 67 68.8 + 2.0 51 78.2 + 0.0 64 68.8 + 0.9 65 67.0 + 1.0 51 23.3 70 78.0 + 5.2 64 75.4 + 1.1 71 79.1 + 4.1 71 55.1 70 78.0 + 5.2 63 85.3 51 76.7 68 11.7 61 62.6 47 + 0.9
47 沖縄 81 80.8 82 76.7 + 2.9 75 86.0 + 0.2 78 79.8 + 1.1 76 72.7 + 1.4 58 17.9 81 81.6 + 8.5 76 79.6 + 2.3 81 82.5 + 6.2 56 48.7 81 81.6 + 8.5 73 88.7 58 82.1 74 9.6 72 67.2 54 + 1.6
- 全体 - 68.7 - 60.2 - - 77.8 - - 57.3 - - 59.0 - - 23.7 - 71.3 - - 70.6 - - 71.6 - - 45.9 - 71.3 - - 81.0 - 76.3 - 18.4 - 58.0 - + 1.3
※1 地域別の集計は、医療機関および薬局の所在地に基づく。※2 平成29年10月診療分の医科、DPC、調剤レセプトを対象とする。DPCについてはコーディングデータを集計対象とする。※3 数量は、薬価基準告示上の規格単位毎に数えたもの。ただし、経腸成分栄養剤、特殊ミルク製剤、生薬、漢方を除く。※4 ジェネリック医薬品使用割合は、数量ベース新指標にて算出。後発品数量 ÷(後発のある先発品数量+後発品数量)※5 後発品の有無に関する情報は、厚生労働省「各先発医薬品の後発医薬品の有無に関する情報」に基づく。※6 実質院内処方率として、医薬品処方数量に基づいて算出している。(院内処方医薬品数量)/(院内処方医薬品数量+院外処方医薬品数量)※7 実質一般名処方率として、一般名処方加算にヒモ付くレセプト数に基づいて算出している。(一般名処方加算1または2が存在する医科レセプトに、支部、記号、番号、性別、生年月日がヒモ付く調剤レセプトの数)/(調剤レセプトの数)※8 一般名処方加算1が存在する医科レセプトに、支部、記号、番号、性別、生年月日がヒモ付く調剤レセプトのみを集計対象とする。※9 実質院外処方率として、医薬品処方数量に基づいて算出している。(院外処方医薬品数量)/(院内処方医薬品数量+院外処方医薬品数量)※10 (調剤レセプトの加入者の都合で後発品を調剤しなかったコメントレコードのあるレセプト数)/(一般名処方加算が存在する医科レセプトに、支部、記号、番号、性別、生年月日がヒモ付く調剤レセプト数)※11 国公費の記載のあるレセプトを集計対象とする。(地方単独公費のみのレセプトは集計対象外)※12 厚労省「調剤医療費の動向~平成28年度版~」制度別後発医薬品割合(数量ベース)(都道府県別)より、協会一般と全保険者のジェネリック医薬品使用割合の差分。※13 影響度は偏差値50からの差分が、県全体のジェネリック医薬品使用割合に与える影響を示す。例えば、影響度が+0.6ならば、当該指標が県全体のジェネリック割合を0.6ポイント引き上げていることを意味する。 影響度は、該当指標の全体平均からの差分に数量構成割合の比率を乗じて算出している。数量構成割合は地域によって異なるため、全体の影響度とその内訳の合計は必ずしも一致しない。
病院 診療所病院 診療所
入院外来
院内処方ジェネリック医薬品使用割合院内処方率(※6)
一般名処方率(※7)
都道府県コード
都道府県名※1
ジェネリック医薬品使用割合(全体)(※2、3、4、5)
院内処方 院外処方
【薬局の視点】 【患者の視点】
加入者ジェネリック拒否割合(※10)
公費対象者ジェネリック医薬品使用割合(※11)
全保険者とのジェネリック医薬品使用割合の乖離(※12)
調剤ジェネリック医薬品使用割合(院外処方再掲)
一般名処方限定調剤ジェネリック医薬品使用割合(※8)
院外処方率(※9)